May 1, 2019 - Experimental Treatment Could Be "Game-Changing" For Inherited ALS

The results of a Phase 2 trial using a drug strategy pioneered by our director, Richard Smith M.D., in collaboration with Ionis Pharmaceuticals and the University of California, San Diego has been reported to demonstrate promising results in a Biogen-sponsored treatment trial. Click here for more information.


© 2020 by Center for Neurologic Study.